- Moving Beyond Change Efforts: Evidence and Action to Support and Affirm LGBTQI+ Youth
- FDA Approves Over-the-Counter Sales of Nasal Spray Narcan
- Xylazine Test Strips Will Soon Be Available
- Taking Buprenorphine After Nonfatal Opioid Overdose Lowers Risk of Future Overdose Death
- Policy News Roundup: March 30, 2023
- Research News Roundup: March 30, 2023
- Buprenorphine initiation in the ER found safe and effective for individuals with OUD who use fentanyl
- Increased Telehealth Services, OUD Medications During COVID-19 Associated with Reduced Fatal Overdose Risk
- Increased Use of Telehealth Services and Medications for Opioid Use Disorder During the COVID-19 Pandemic Associated with Reduced Risk for Fatal Overdose
- DEA Warns of Widespread Threat of Fentanyl Mixed With Xylazine
- New NIH study reveals shared genetic markers underlying substance use disorders
- Mission Moment – March 2023
- Guest Author – March 2023
- Officer of the Month – March 2023
- Partnership to End Addiction’s New Documentary to Stream on Peacock, The Roku Channel, Redbox, Crackle, Amazon Freevee and Tubi
